These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9814057)

  • 41. [Antineoplastic agents. Part 1].
    Fouquoire V
    Rev Infirm; 1996 Feb; (3):33-6. PubMed ID: 8850708
    [No Abstract]   [Full Text] [Related]  

  • 42. The seven main requirements for a potential antineoplastic agent.
    Ullman SB
    Arch Geschwulstforsch; 1970; 36(1):34-7. PubMed ID: 5491210
    [No Abstract]   [Full Text] [Related]  

  • 43. Letter: Kinetic classifications of Antitumour Drugs.
    Hill BT; Price LA
    Br Med J; 1975 Aug; 3(5979):367. PubMed ID: 1156762
    [No Abstract]   [Full Text] [Related]  

  • 44. [Anticancer chemotherapy (including hormone therapy). Classification, mode of action, main side effects].
    Brun B; Piedbois P
    Rev Prat; 1994 Nov; 44(17):2367-77. PubMed ID: 7984948
    [No Abstract]   [Full Text] [Related]  

  • 45. [Re: "Current role of chemotherapy in the treatment of hormone-resistant metastatic prostate cancer" by Xavier Breton, Eric Lechevallier, Christian Coulange, Prog. Urol., 2005, 15, 398-404].
    Berdah JF
    Prog Urol; 2005 Dec; 15(6):1160. PubMed ID: 16429675
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antineoplastic chemotherapy (hormone therapy included): classification, main secondary effects].
    Brun B; Piedbois P
    Rev Prat; 1998 Sep; 48(14):1587-600. PubMed ID: 9814057
    [No Abstract]   [Full Text] [Related]  

  • 47. [Development of cancer chemotherapy. The discovery of new active drugs. II].
    Lopez M
    Clin Ter; 1998; 149(6):453-9. PubMed ID: 10100409
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of hormone-refractory disease.
    Hennequin C
    BJU Int; 2004 Dec; 94 Suppl 3():16-7. PubMed ID: 15521889
    [No Abstract]   [Full Text] [Related]  

  • 49. Advances in chemotherapy options for metastatic breast cancer: introduction of epothilones.
    McGee L
    ONS Connect; 2007; 22(8 Suppl):29-30. PubMed ID: 17824553
    [No Abstract]   [Full Text] [Related]  

  • 50. Hormonal therapy for advanced breast cancer.
    Rugo HS
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):273-91. PubMed ID: 17512449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Apoptosis and chemotherapy].
    Bettaieb A; Sordet O; Belon JP; Solary E
    Bull Cancer; 1999 Jan; 86(1):41-6. PubMed ID: 10029703
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problems in oncologic pharmacology].
    Filov VA; Gershanovich ML; Akimov MA; Akimov AA
    Vopr Onkol; 1998; 44(6):651-61. PubMed ID: 10087958
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.